Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

Author： Porta Camillo Mutti Luciano Tassi Gianfranco

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.1, 2007-01, pp. : 149-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Malignant pleural mesothelioma

By Stahel Rolf A Felley-Bosco Emanuela Opitz Isabelle Weder Walter

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Surgical Treatment of Malignant Pleural Mesothelioma

By Kaufman Andrew

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 201-216

Springer Publishing Company

Access to resources Recommend Favorite

Systemic treatment of malignant pleural mesothelioma

By Grosso Federica Scagliotti Giorgio Vittorio

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 293-305

Future Medicine

Access to resources Recommend Favorite

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

By van Meerbeeck J.P. Baas P. Debruyne C. Smit E.F. van Klaveren R.J. Galdermans D. Lentz M.A. Manegold C. Giaccone G. for the EORTC Lung Cancer Group

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 779-783

Elsevier

Access to resources Recommend Favorite